Yajun Liu

Yajun Liu currently serves as the Director of Clinical Pharmacology at Jazz Pharmaceuticals since April 2025, having previously held the same title at Repare Therapeutics from October 2022 to March 2025, where Yajun led the clinical pharmacology and quantitative PK/PD strategies for oncology development programs. Prior experience includes serving as a Senior Clinical Pharmacology Reviewer for oncology at the FDA from May 2014 to October 2022, and a Clinical Pharmacology Reviewer in Bioequivalence at Merck from May 2013 to April 2014. Yajun began a career in academia as a Graduate Research Assistant at the University of Michigan, where a Ph.D. in Pharmaceutical Sciences was obtained in 2013, following a M.S. in Pharmaceutics from Shanghai Jiao Tong University in 2008.